LONDON BROKER RATINGS: Stifel raises Rentokil to 'buy' from 'hold'
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
| Price | 299.70p on 07-10-2026 at 12:16:49 |
|---|---|
| Change | 0.70p 0.23% |
| Buy | 299.60p |
| Sell | 299.50p |
| Last Trade: | Sell 200.00 at 299.512p |
| Day's Volume: | 1,603,659 |
| Last Close: | 299.00p |
| Open: | 297.50p |
| ISIN: | GB00B082RF11 |
| Day's Range | 296.50p - 301.30p |
| 52wk Range: | 293.50p - 506.80p |
| Market Capitalisation: | £7.54b |
| VWAP: | 299.15753p |
| Shares in Issue: | 2.52b |
Rentokil Initial (RTO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 200 | 299.512p | Negotiated Trade |
13:16:49 - 07-Oct-26 |
| Sell* | 899 | 299.70p | Automatic Execution |
13:15:46 - 07-Oct-26 |
| Sell* | 1,370 | 299.70p | Automatic Execution |
13:15:46 - 07-Oct-26 |
| Sell* | 244 | 299.70p | Automatic Execution |
13:15:46 - 07-Oct-26 |
| Buy* | 30 | 299.80p | Automatic Execution |
13:14:07 - 07-Oct-26 |
| Buy* | 219 | 299.80p | Automatic Execution |
13:14:07 - 07-Oct-26 |
| Buy* | 381 | 299.80p | Automatic Execution |
13:14:07 - 07-Oct-26 |
| Buy* | 412 | 299.80p | Automatic Execution |
13:14:07 - 07-Oct-26 |
| Buy* | 302 | 299.80p | Automatic Execution |
13:14:07 - 07-Oct-26 |
| Sell* | 694 | 299.747p | Ordinary |
13:13:43 - 07-Oct-26 |
Rentokil Initial (RTO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Oct 2026 11:15 am | RNS | Holding(s) in Company |
| 30th Sep 2026 10:25 am | RNS | Holding(s) in Company |
| 22nd Sep 2026 7:00 am | RNS | Sale of SOLitude Lake Management, LLC |
| 27th Aug 2026 3:00 pm | RNS | Interim Dividend – Pence Sterling Amount Payable |
| 13th Aug 2026 9:30 am | RNS | Organisational Changes & Leadership Appointments |
| 4th Aug 2026 10:30 am | RNS | Holding(s) in Company |
| 3rd Aug 2026 1:00 pm | RNS | Director/PDMR Shareholding |
| 30th Jul 2026 7:00 am | RNS | Half-year Financial Report |
| 16th Jul 2026 10:00 am | RNS | Director Declaration |
| 21st May 2026 7:00 am | RNS | Appointment of CEO, North America |